Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition
Key facts
- Who runs it
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Where
- Mexico1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 375 people, planned
- Started
- 1 Feb 2026
- Expected to end
- 30 Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Isocaloric diet including chia and pumpkin seeds
- Isocaloric diet
- Record updated
- 14 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 28 criteriaShow less
Who can take part
- Signing of the informed consent form
- Both sexes
- Adults over 18 years of age
- BMI >18.5 kg/m2
- Triglycerides between 200 and 500 mg/dL
- Total cholesterol less than 240 mg/dL
Who cannot take part
- Treatment with any medication:
- Treatment with hypoglycemic agents (sulfonylureas, biguanides, incretins) or - insulin and antidiabetics
- Treatment with statins, fibrates, or other drugs to control dyslipidemia
- Use of steroid medications, chemotherapy, immunosuppressants, or radiation therapy
- Treatment with any medication that influences inflammation (corticosteroids, nonsteroidal anti-inflammatory drugs, colchicine, interleukin-1 inhibitors) or triglyceride metabolism (metformin, glitazones, SGLT2 inhibitors, fibrates, statins, cholesterol ester transporter protein (CETP) inhibitors, pancreatic lipase inhibitors)
- Previous n-3 PUFA supplementation
- Any type of diabetes
- kidney disease diagnosed by a physician
- Acquired diseases that secondarily cause obesity and diabetes
- Catabolic diseases such as cancer and acquired immunodeficiency syndrome
- Allergy or intolerance to any food listed in the proposed pantry
- Treatment with antihypertensive drugs (tricyclic, loop, or potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers, alpha-blockers, calcium channel blockers, beta-blockers)
- Patients who have suffered a cardiovascular event
- Weight loss >3 kg in the last 3 months
- Pregnancy
- Anorectic agents or those that accelerate weight loss
- Anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel)
- People with a smoking cessation index (SCI) greater than 21
- People with a tobacco Index greater than 21
- Consumption of large amounts of alcohol (14 drinks for women or 21 drinks for men in a typical week)
- Consumption of any recreational psychoactive substance
- Unwillingness to consume any of the foods listed in the proposed pantry
This trial is currently available in Mexico.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Hypertriglyceridemia is one of the most prevalent lipid profile disorders and is linked to a large proportion of mortality in Mexico and around the world. Various international treatment guidelines for hypertriglyceridemia have suggested the consumption of foods rich in n-3 polyunsaturated fatty acids or their intake through supplementation as a complement to lifestyle changes. However, adherence to the consumption of foods and supplements containing these fatty acids is often limited due to lack of acceptance or unaffordability. For this reason the objective of the study is to evaluate the effect of including Mexican foods rich in n-3 polyunsaturated fatty acids (chia seeds and pumpkin seeds) within a diet based on NCEP-ATPIII recommendations on triacylglycerol concentration and fatty acid profile in people with hypertriglyceridemia.
Read full original descriptionShow less
The study will consist of a 4-week period in which one group of participants will be randomized into two treatment groups: 1)isocaloric diet based on the NCEP-ATPIII dietary recommendations; 2) isocaloric diet based on the NCEP-ATPIII dietary recommendations plus chia and pumpkin seeds. The effect of the dietary intervention will be assessed by concentration of triglycerides, fatty acids profile and lipoprotein analysis.
The 2 groups in the trial
- Isocaloric diet based on NCEP-ATPIII dietary recommendations including chia and pumpkin seeds.Treatment being tested
Diet based on participant-specific energy expenditure. With the following macronutrient distribution: 50% carbohydrates, protein 20% and 30% fats.
Treatment: Isocaloric diet including chia and pumpkin seeds
- Isocaloric diet based on NCEP-ATPIII dietary recommendationsExisting treatment, for comparison
Diet based on participant-specific energy expenditure. With the following macronutrient distribution: 50% carbohydrates, protein 20% and 30% fats.
Treatment: Isocaloric diet
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition in Individuals With Hypertriglyceridemia. Controlled Clinical Trial.
- Record updated
- 14 April 2026